135 related articles for article (PubMed ID: 14750537)
1. Hormone replacement therapy in relation to survival in women diagnosed with colon cancer.
Mandelson MT; Miglioretti D; Newcomb PA; Harrison R; Potter JD
Cancer Causes Control; 2003 Dec; 14(10):979-84. PubMed ID: 14750537
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis.
Nanda K; Bastian LA; Hasselblad V; Simel DL
Obstet Gynecol; 1999 May; 93(5 Pt 2):880-8. PubMed ID: 10912438
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA).
Slattery ML; Anderson K; Samowitz W; Edwards SL; Curtin K; Caan B; Potter JD
Cancer Causes Control; 1999 Oct; 10(5):467-73. PubMed ID: 10530618
[TBL] [Abstract][Full Text] [Related]
4. Association of hormone replacement therapy with mortality in colorectal cancer survivor: a systematic review and meta-analysis.
Jang YC; Huang HL; Leung CY
BMC Cancer; 2019 Dec; 19(1):1199. PubMed ID: 31818262
[TBL] [Abstract][Full Text] [Related]
5. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy?
Olsson H; Bladström A; Ingvar C
Obstet Gynecol; 2003 Sep; 102(3):565-70. PubMed ID: 12962944
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and colon cancer among members of a health maintenance organization.
Jacobs EJ; White E; Weiss NS; Heckbert SR; LaCroix A; Barlow WE
Epidemiology; 1999 Jul; 10(4):445-51. PubMed ID: 10401882
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer in women: hormone replacement therapy and chemoprevention.
Barnes EL; Long MD
Climacteric; 2012 Jun; 15(3):250-5. PubMed ID: 22612611
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
Grimes DA; Lobo RA
Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
[TBL] [Abstract][Full Text] [Related]
9. Lifestyle influences on the association between pre-diagnostic hormone replacement therapy and breast cancer prognosis - results from The Danish 'Diet, Cancer and Health' prospective cohort.
Holm M; Olsen A; Kroman N; Tjønneland A
Maturitas; 2014 Dec; 79(4):442-8. PubMed ID: 25304746
[TBL] [Abstract][Full Text] [Related]
10. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial.
Woodson K; Lanza E; Tangrea JA; Albert PS; Slattery M; Pinsky J; Caan B; Paskett E; Iber F; Kikendall JW; Lance P; Shike M; Weissfeld J; Schatzkin A
J Natl Cancer Inst; 2001 Dec; 93(23):1799-805. PubMed ID: 11734596
[TBL] [Abstract][Full Text] [Related]
12. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
13. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
Beral V; Banks E; Reeves G
Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women.
Lindblad BE; Håkansson N; Philipson B; Wolk A
Ophthalmology; 2010 Mar; 117(3):424-30. PubMed ID: 20045566
[TBL] [Abstract][Full Text] [Related]
15. Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.
Daling JR; Malone KE; Doody DR; Voigt LF; Bernstein L; Marchbanks PA; Coates RJ; Norman SA; Weiss LK; Ursin G; Burkman RT; Deapen D; Folger SG; McDonald JA; Simon MS; Strom BL; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1175-81. PubMed ID: 14652277
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II.
Hildebrand JS; Jacobs EJ; Campbell PT; McCullough ML; Teras LR; Thun MJ; Gapstur SM
Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2835-41. PubMed ID: 19843681
[TBL] [Abstract][Full Text] [Related]
17. Comparison of associations of body mass index, abdominal adiposity, and risk of colorectal cancer in a large prospective cohort study.
Keimling M; Renehan AG; Behrens G; Fischer B; Hollenbeck AR; Cross AJ; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1383-94. PubMed ID: 23720402
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
[TBL] [Abstract][Full Text] [Related]
19. Interactions of familial and hormonal risk factors for large bowel cancer in women.
Newcomb PA; Taylor JO; Trentham-Dietz A
Int J Epidemiol; 1999 Aug; 28(4):603-8. PubMed ID: 10480684
[TBL] [Abstract][Full Text] [Related]
20. Body mass and colorectal cancer risk in the NIH-AARP cohort.
Adams KF; Leitzmann MF; Albanes D; Kipnis V; Mouw T; Hollenbeck A; Schatzkin A
Am J Epidemiol; 2007 Jul; 166(1):36-45. PubMed ID: 17449892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
